Fig. 4
From: RNA-Seq profiling of deregulated miRs in CLL and their impact on clinical outcome
Cumulative incidence plots demonstrating risk of treatment in CLL patients stratified on the basis of level of expression of a miR-4524a, b IGHV mutation status, and c miR-744. The cut-offs for defining low and high expression of miRNA and the number of cases in each subgroup are shown below the curves. p-values and hazard ratios as obtained in the Fine- Gray model of multivariate analysis is shown inside the curve.
